Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Osteoporosis Prevention in Prostate Cancer Patients on Androgen Ablation
NCT00043069Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Nov 2002
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of risedronate, conjugated estrogens in osteoporosis, sponsored by Cancer and Leukemia Group B. Started Nov 2002; status: completed.
02
Drugs
risedronateconjugated estrogens
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00043069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043069.